DTC Advisory Review Fee To Vary Based On Number Of Expected Submissions
Executive Summary
Under the Prescription Drug User Fee Act agreement between FDA and industry, the level of user fees for advisory review of direct-to-consumer television ads will depend on the number of ads sponsors expect to submit for review during a given year